Author Correction: Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
26 Apr 2019
Historique:
entrez: 28 4 2019
pubmed: 28 4 2019
medline: 28 4 2019
Statut: epublish

Résumé

This Article contains an error in the last sentence of the 'Variant analysis suggests they are pathogenic' section of the Results, which incorrectly reads 'No truncated PIEZO1 protein products were identified in western blot analysis in GLD1:II.3 and GLD2:II.2 (Fig. 2, Supplementary Fig. 6), suggesting that the truncated protein is not stable and therefore degraded.' This should read 'No full-size PIEZO1 protein products were identified in western blot analysis in GLD1:II.3 and GLD2:II.2 (Fig. 2, Supplementary Fig. 6); the three nonsense mutations are predicted to lead to premature termination of the protein, hence it is possible that those truncated proteins will be non-functional or even unstable and degraded.' The error has not been fixed in the PDF or HTML versions of the Article.

Identifiants

pubmed: 31028252
doi: 10.1038/s41467-019-09905-4
pii: 10.1038/s41467-019-09905-4
pmc: PMC6486644
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1951

Commentaires et corrections

Type : ErratumFor

Auteurs

Elisavet Fotiou (E)

Cardiovascular and Cell Sciences Institute, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK.

Silvia Martin-Almedina (S)

Cardiovascular and Cell Sciences Institute, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK.

Michael A Simpson (MA)

Department of Medical and Molecular Genetics, Division of Genetics and Molecular Medicine, Kings College London School of Medicine, Guy's Hospital, London, SE1 9RY, UK.

Shin Lin (S)

Division of Cardiovascular Medicine, Stanford University, Stanford, California, 94305, USA.
Department of Genetics, Stanford University, Stanford, California, 94305, USA.

Kristiana Gordon (K)

Department of Dermatology, St. George's Healthcare NHS Trust, London, SW17 0QT, UK.

Glen Brice (G)

South West Thames Regional Genetics Unit, St. George's University of London, London, SW17 0RE, UK.

Giles Atton (G)

South West Thames Regional Genetics Unit, St. George's University of London, London, SW17 0RE, UK.

Iona Jeffery (I)

Pathology Department, St. George's University of London, London, SW17 0RE, UK.

David C Rees (DC)

Department of Haematological Medicine, King's College London School of Medicine, King's College Hospital, London, SE5 9RS, UK.

Cyril Mignot (C)

Département de Génétique, APHP, GH Pitié-Salpêtrière, Centre de Référence des Déficiences Intellectuelles de Causes Rares, 75013, Paris, France.

Julie Vogt (J)

West Midlands Regional Genetics Service, Clinical Genetics Unit, Birmingham Women's Hospital, Birmingham, B15 2TG, UK.

Tessa Homfray (T)

South West Thames Regional Genetics Unit, St. George's University of London, London, SW17 0RE, UK.

Michael P Snyder (MP)

Department of Genetics, Stanford University, Stanford, California, 94305, USA.

Stanley G Rockson (SG)

Division of Cardiovascular Medicine, Stanford University, Stanford, California, 94305, USA.

Steve Jeffery (S)

Cardiovascular and Cell Sciences Institute, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK.

Peter S Mortimer (PS)

Cardiovascular and Cell Sciences Institute, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK.

Sahar Mansour (S)

South West Thames Regional Genetics Unit, St. George's University of London, London, SW17 0RE, UK.

Pia Ostergaard (P)

Cardiovascular and Cell Sciences Institute, St. George's University of London, Cranmer Terrace, London, SW17 0RE, UK. posterga@sgul.ac.uk.

Classifications MeSH